Category: Researcher Profiles
... for airways disease that target neutrophilic inflammation such as macrolide antibiotics. Identifying the mechanisms of neutrophilic inflammation - ... conducted and published the first randomised controlled trials of macrolide therapy (a type of antibiotics) for patients with difficult ...
Category: News & Articles
A national study investigating the use of antibiotics as a potential therapy for chronic asthma attacks is ... years after it commenced. A national study investigating the use of antibiotics as a potential therapy for chronic asthma attacks is ... a placebo tablet. “We showed in a previous study of 45 people that macrolide antibiotics can reduce inflammation and improve quality of ...
Category: Researcher Profiles
... is to develop a new treatment for non-eosinophilic asthma with macrolide antibiotics. Eosinophils are a form of white blood cells in the immune ...
Category: News & Articles
... in the study. “In a previous study of 45 people we have shown that macrolide antibiotics can reduce inflammation and improve quality of life for ... Hospital. “In the AMAZES study we are looking at the effect of macrolide antibiotics on asthma attacks, as well as how they modify ...
Category: News & Articles
... also developing a new treatment for non-eosinophilic asthma using macrolide antibiotics. Results of his ‘AMAZES’ study published in leading ... reduced by 40 per cent with a low daily dosage of Azithromycin, a macrolide antibiotic. It benefited asthma sufferers whose symptoms were ...
Category: News & Articles
... at the time, to undertake the Australia-wide multicentre study of macrolide antibiotics in asthma (AMAZES) study. The AMAZES trial, which showed ...
Category: News & Articles
... the disease and the treatment of non-eosinophilic asthma with macrolide antibiotics. Now in its 32nd year, the Award for Research Excellence ...
Category: General
... Jodie reported the findings of the first randomised clinical trial of macrolide antibiotics for patients with severe asthma. She is now co-leading the ...